Stephan A Grupp Selected Research

Stem Cell Transplantation

1/2021	Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.
1/2020	Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study.
1/2017	Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
10/2016	Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation.
9/2013	Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
9/2010	Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
12/2009	A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).
9/2009	Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan A Grupp Research Topics

Disease

63	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 08/2002
54	Neoplasms (Cancer) 01/2022 - 03/2004
29	Leukemia 01/2022 - 01/2003
26	Cytokine Release Syndrome 01/2022 - 04/2013
19	Neuroblastoma 01/2020 - 03/2004
18	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2011
9	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021 - 08/2011
8	Lymphoma (Lymphomas) 05/2021 - 12/2003
6	Residual Neoplasm 01/2022 - 09/2009
6	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021 - 03/2016
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 12/2009
5	Autoimmune Lymphoproliferative Syndrome 01/2016 - 09/2006
4	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 06/2013
4	Infections 01/2021 - 03/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2010
3	Critical Illness (Critically Ill) 10/2020 - 01/2016
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 10/2012
3	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 02/2010
3	Splenomegaly 01/2016 - 02/2006
3	Cytopenia 01/2016 - 03/2010
3	Lymphadenopathy 01/2016 - 09/2006
3	Macrophage Activation Syndrome 09/2014 - 02/2014
3	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 09/2009 - 08/2002
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2022 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2022 - 01/2017
2	cell-associated neurotoxicity 01/2022 - 12/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 01/2018
2	Fever (Fevers) 10/2021 - 02/2017
2	Hemorrhage 01/2021 - 03/2016
2	Hypersensitivity (Allergy) 11/2020 - 09/2010
2	COVID-19 11/2020 - 01/2020
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 06/2009
2	Multiple Myeloma 01/2018 - 01/2018
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 06/2009
2	Hyperferritinemia 02/2017 - 06/2013
2	Pneumonia (Pneumonitis) 01/2015 - 01/2013
2	Body Weight (Weight, Body) 10/2014 - 04/2013
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2012 - 06/2009
2	Bronchiolitis Obliterans Syndrome 01/2012 - 12/2011
1	Down Syndrome (Down's Syndrome) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 10/2021

Drug/Important Bio-Agent (IBA)

59	Chimeric Antigen ReceptorsIBA 10/2022 - 08/2011
26	tisagenlecleucelIBA 01/2022 - 04/2013
14	CytokinesIBA 11/2020 - 01/2008
13	AntigensIBA 01/2020 - 08/2009
10	Sirolimus (Rapamycin)FDA Link 01/2016 - 01/2003
9	tocilizumab (atlizumab)FDA Link 01/2022 - 04/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
7	Monoclonal AntibodiesIBA 01/2018 - 09/2010
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2014
6	defibrotideIBA 01/2021 - 03/2016
6	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2004
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2019 - 08/2011
5	Surface Antigens (Surface Antigen)IBA 10/2018 - 01/2012
4	blinatumomabIBA 01/2022 - 06/2013
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 03/2010
4	AntibodiesIBA 01/2016 - 01/2008
4	TOR Serine-Threonine KinasesIBA 10/2012 - 12/2003
4	MTOR InhibitorsIBA 10/2012 - 10/2007
3	CD19 AntigensIBA 01/2022 - 12/2014
3	Messenger RNA (mRNA)IBA 01/2021 - 12/2011
3	Phosphotransferases (Kinase)IBA 12/2017 - 08/2012
2	siltuximabIBA 01/2022 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 11/2020 - 01/2017
2	Biological ProductsIBA 10/2020 - 09/2014
2	CD19-specific chimeric antigen receptorIBA 01/2020 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2008
2	Death Domain ReceptorsIBA 01/2020 - 12/2010
2	Pharmaceutical PreparationsIBA 11/2019 - 01/2019
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 03/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 08/2002
2	Bispecific AntibodiesIBA 07/2014 - 02/2014
2	Interleukin-2 (IL2)IBA 05/2014 - 09/2010
2	InterleukinsIBA 03/2014 - 02/2014
2	InterferonsIBA 03/2014 - 02/2014
2	Isotretinoin (Accutane)FDA LinkGeneric 09/2013 - 09/2010
2	Etanercept (Enbrel)FDA Link 04/2013 - 01/2013
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2013 - 12/2009
2	temsirolimus FDA Link 07/2011 - 02/2006
2	Methotrexate (Mexate)FDA LinkGeneric 12/2009 - 09/2008
2	SurvivinIBA 12/2006 - 03/2004
2	SteroidsIBA 01/2003 - 08/2002
1	CytosineIBA 11/2022
1	ProteomeIBA 01/2022
1	EmapalumabIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	GlucocorticoidsIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022

Therapy/Procedure

67	Therapeutics 07/2022 - 08/2002
24	Immunotherapy 01/2022 - 03/2004
12	Hematopoietic Stem Cell Transplantation 01/2019 - 02/2010
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
8	Stem Cell Transplantation 01/2021 - 09/2009
7	Transplantation 01/2022 - 06/2006
7	Cell Transplantation 01/2021 - 12/2009
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 02/2010
4	Induction Chemotherapy 01/2020 - 11/2012
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2020 - 09/2013
2	Radiotherapy 01/2020 - 09/2013